135 results about "Treatment duration" patented technology

The system of remotely controlling the medical laser generator unit through a portable computing device such as a smart phone or a tablet personal computer allows the user to control the properties of the medical laser with a downloadable software application. The portable computing device and the medical laser generator unit communicate with each other through a network connection, which can be either a hard-wired link or a wireless link. The properties of the medical laser that can be controlled by the software application include emission power, pulse structure, and treatment duration. The software application is also able to retrieve feedback data from the patient during a medical procedure. The feedback data includes tissue color, tissue temperature, and a laser plume signature. The software application also allows the user to access each individual patient's medical information so that the user can better perform the medical procedure.

A method and system for treating dysphagia using electrical stimulation of a human's or animals's vagus nerve, or recurrent laryngeal nerve, or both to cause glottic or vocal fold motion in humans or animals. Stimulation is caused by utilizing a power source; an external controller for generating and providing an output signal having a given intensity, frequency, and pulse duration; an output protector circuit for limiting the intensity of the output signal; a treatment duration circuit for controlling the duration of operation of the external controller, a ramp control circuit for controlling the intensity of the output signal; and a monitor portion for displaying operating parameters of the device. The external controller regulates the intensity, the frequency, and the pulse duration of the output signal in accordance with a procedure for treating dysphagia.

A noninvasive method and apparatus for treating living tissue with pulsed electromagnetic fields (PEMFs) having selectively reduced high-frequency signal components, with improved bioresponse provided by magnetic field amplitudes less than approximately 40 μT, and most preferably in the range of 4–10 μT. Such amplitude levels for the disclosed PEMF signal are particularly effective with a treatment duration in the range of 0.25–2 hours / day.

A blood purification device that does not require measurement of a patient's blood concentration performed ahead of time and that allows treatment time to be reduced, thus reducing the burden on the patient, and allows monitoring of problems in the internal elements. The present invention includes: blood purification device main units including a blood pump disposed in an arterial blood circuit, a blood purification device purifying blood, and an ultrafiltration pump for draining water from blood; first measuring means and second measuring means measuring hematocrit values and disposed at the arterial blood circuit and the venous blood circuit respectively; calculating means calculating a ratio for measured hematocrit values and a ratio for a theoretical hematocrit values determined from a predetermined equation and evaluating means evaluating whether the values determined by calculating means are roughly similar.

A comparative orthodontic treatment planning tool that can provide multiple treatment plan options based on a single initial tooth data set. A user can use the treatment planning tool to select a treatment plan based on factors, including cost, treatment duration, treatment complexity, and material or feature selection. Tooth arrangements at different treatment stages can be compared. In some cases, a tooth arrangement at one treatment stage can be superimposed over a tooth arrangement at a different treatment stage or over a tooth arrangement from a different treatment plan.

The present invention provides a blood treatment device and methods of blood treatment to provide an individual patient with the most suitable blood treatment and reduced treatment duration. Specifically, the invention provides a blood treatment device comprising a treating means 11 that treats blood collected from a patient; a measuring means 12 that measures parameters of the patient's blood and indicates blood condition; a controlling means 13 that controls the treatment procedures based upon the blood parameters; a storing means 15 that records an ideal patient-specific blood parameter curve for the treatment duration; and a directing means 14 that directs the control by the controlling means 13 so that the measured blood parameters approximate to the ideal blood parameter curve by comparing the measured blood parameters with the ideal blood parameter curve recorded by the storing means 15.

The invention discloses a light foamed soil for abutment back backfilling. The light foamed soil comprises cement, a mixed material, water, a conditioning agent, a foaming agent, a micro-foam agent, and a waterproof agent. The invention also provides a preparation method of light foamed soil for abutment back backfilling. The micro-foam agent is prepared into foams by a plunger pump and an air compressor, the materials are mixed and stirred by a stirrer, and the slurry extraction speed is controlled by a frequency converter so as to control the volume weight of the finished product. The invention also provides an on-site construction method of light foamed soil applied to abutment back backfilling. The light foamed soil provided by the invention belongs to light materials, has small foundation load after filling, greatly reduces the foundation treatment intensity, and saves the foundation treatment duration. After pouring and before initial setting, light foamed soil has very good fluidity and fill self-compaction, avoids the defect of non-full filling of conventional fillers, has strong constructability, and can effectively solve the phenomenon of bumping at bridge head.

This invention is directed towards a patient single surface system, PS3, which is a next generation system solution for patient accommodation, diagnosis, treatment, transfer and transport. PS3 provides a single surface for the patient to remain on from the trauma site through diagnosis, treatment and convalescence. Needs addressed by the PS3 system include improved patient treatment through reduction in time to treatment, reduced or eliminated unnecessary patient movement and injury, as well as improved comfort throughout treatment and convalescence. In addition, the PS3 system solves significant economic considerations.

The invention relates to a device and a method for treating tumors through irreversible electroporation, belonging to the technical field of tumor treatment. The device mainly comprises a square wave pulse generation and measurement system, a signal conversion system, a man-machine communication system, a measurement control system and a power supply system. In the method, the device and a therapeutic electrode are used for treating the tumors through a program. Under the circumstance of no injection of chemotherapeutic drugs, microsecond square wave pulses are applied to tumor tissues, the entire tumor cell is fully damaged, so that the tumor cell dies due to irreversible electroporation, and the harm on the body of a patient caused by the side effect of the chemotherapeutic drugs is radically avoided. The invention has the characteristics of short treatment time, no pain, good treatment effect, high safety, convenient use, simple operation, convenient popularization and application and the like. The device and the method can be widely used for treating the tumors of human and animals, and are especially applicable to human tumor treatment.

A selectively loadable / sealable bioresorbable carrier assembly for retaining and positioning elements used in brachytherapy procedures comprises a bioresorbable tube having a closed distal end and a proximal open end. The bioresorbable tube is loaded with a selectable arrangement of elements, including at least one radioactive seed, through the proximal open end. After the bioresorbable tube is selectably loaded, the bioresorbable tube is heat sealed at a sealing position adjacent a proximalmost element. Once sealed, the bioresorbable tube maintains the arrangement of elements throughout the treatment duration.

The invention provides methods and systems for assessing the efficacy of a pharmaceutical which is putatively disease modifying of a cognitive disorder, for use in the treatment or prophylaxis of that cognitive disorder, the method comprising the steps of: (1) stratifying a subject group into at least 2 sub-groups according to a baseline indicator of likely disease progression, (2) treating members of each subject group with the pharmaceutical for a treatment time frame, (3) deriving psychometric and optionally physiological outcome measures for each treated patient group, (4) comparing the outcomes at (3) with a comparator arm of said sub-groups which is optionally a placebo or minimal efficacy comparator arm, (5) using the comparison in (4) to derive an efficacy measure for the pharmaceutical. The methods and systems of the invention address problems such as low rate of decline over the treatment time-frame of patients who have mild-disease severity at baseline and biased withdrawal, particularly in the placebo / comparator treatment arm.

The invention discloses Chinese medicinal capsules for treating primitive high blood pressure of people in middle and old age, which are prepared from the following Chinese medicinal materials (by weight proportion): dried rehmannia root, prepared rhizome of rehmannia each 9.5-11.0%, fleece-flower root, mulberry seeds, ligustrum japonicum, flatstem milkvetch seed, puncturevine, cynomorium songaricum, achyranthes root, dodder seed, radish seeds, white atractylodes rhizome, wolfberry fruit 4.0-6.0%, plantain seeds, cassia seed each 6.5-7.0%, wild chrysanthemum flower, polygala root, acorus gramineus soland each 2.6-4.0%, asarum herb 0.2-2.0%.

This invention are computer implementable programs and method designed as medical planning tool that (1) models the patient flow from the point of injury through more definitive care, and (2) supports operations research and systems analysis studies, operational risk assessment, and field medical services planning. The computer program of this invention comprises six individual modules, including the casualty generation module, which uses an exponential distribution to stochastically generate wounded in action, disease, and nonbattle injuries; a care providing module uses generic task sequences, simulated treatment times, and personnel, consumable supply, and equipment requirements to model patient treatment and queuing within a functional area; a network / transportation module simulates the evacuation (including queuing) and routing of patients through the network of care via transportation assets; a reporting module produces an database detailing various metrics, such as patient disposition, time-in-system data, and consumable, equipment, personnel, and transportation utilization rates, which can be filtered according to the user's needs.

A method and system for automated and semi-automated predictable, consistent, safe, effective, and lumen-specific and patient-specific cryospray treatment of airway tissue in which treatment duration is automatically set by the system following entry of patient information and treatment location information into the system by the user, and treatment spray is automatically stopped by the system when the automatically selected treatment duration has been achieved as determined by the system.

Drugs for treating dysmenorrheal belong to the field of traditional Chinese medicines. Aiming at the basic causes of dysmenorrheal that stagnation causes pains as well as cold stagnation and blocks are caused, the drugs adopt the Chinese medicine theories to seek the basic causes when treating diseases and achieve the effects of warming a uterus and relieving pains at the same time so as to treat dysmenorrheal. The drugs are prepared from the following effective constituents by weight portion: syzygium aromaticum, Chinese cinnamon, angelica, evodia rutaecarpa, wild gingers, rhizoma corydalis, szechuan lovage rhizome, safflowers and mugwort leaves. The drugs are simple to prepare, and have the advantages of low price, good curative effect, no toxic and side effects, short treatment time and good social and economic benefits. A plurality of drugs can achieve compatibility; in addition, the drugs aim at the basic causes of dysmenorrheal that stagnation causes pains as well as cold stagnation and blocks are caused, can seek the basic causes when treating diseases, and can achieve the curative effects of warming the uterus and relieving pains at the same time.

A device and method is disclosed for the treatment of early stage wounds, i.e. those wounds that have resulted in little or no breach of the skin tissue. The invention utilizes non-ablative laser or non-coherent electromagnetic radiation applied to a stage one or two wound to stimulate wound healing, destroy viral and bacterial bodies, and prevent the development of such wounds into higher stage wounds. An appropriate wavelength is chosen from the range of 193 nm to 10.6 microns, and is delivered at a power density of about at least 1 W / cm2 over a predetermined treatment duration typically in the range of 1 second to 3 minutes. To achieve the desired energy density, radiation is typically delivered at a power between 1 Watt and 15 Watts, with an average power of 5-10 Watts. Early stage wounds that can be addressed with this invention include but are not limited to spider or other insect bites, bee stings, rashes, eczema, psoriasis, and poison ivy. The present invention is especially useful for patients with a compromised ability to heal or stave off infection due to diabetes or other conditions.

The present invention provides a blood treatment device and methods of blood treatment to provide an individual patient with the most suitable blood treatment and reduced treatment duration. Specifically, the invention provides a blood treatment device comprising a treating means (11) that treats blood collected from a patient; a measuring means (12) that measures parameters of the patient's blood and indicates blood condition; a controlling means (13) that controls the treatment procedures based upon the blood parameters; a storing means (15) that records an ideal patient-specific blood parameter curve for the treatment duration; and a directing means (14) that directs the control by the controlling means (13) so that the measured blood parameters approximate to the ideal blood parameter curve A by comparing the measured blood parameters with the ideal blood parameter curve recorded by the storing means (15).

The invention discloses a plank surface carbonization treatment technology and belongs to the field of wood processing. The technology specifically comprises the steps of 1, plank cutting; 2, plank pre-drying; 3, secondary drying; 4, carbonization; 5, thermal refining. The steps are reasonably matched, cracking of wood during processing can be avoided, and a finished product obtained after processing has high anti-cracking property which is lower than that of conventional planks by only 8% or less, while the anti-cracking property is reduced by 40% or so when a traditional treatment method is adopted. Furthermore, according to the technology, treatment duration is shortened by 30-35%, efficiency is higher, and therefore popularization value is high.

The invention discloses a burn and scald medicine and a preparation method thereof. 100 to 150 portions of calcium oxide prepared from the following components in portion by weight and 400 to 1,500 portions of water are prepared into an aqueous solution, the aqueous solution is stirred, precipitated, clarified and deslagged, and a clear water layer of the aqueous solution is added with borneol which accounts for 0.05 to 0.1 percent of the weight of the aqueous solution and fully stirred and mixed to obtain the medicine. The medicine has the advantages of simple, convenient and quick treatment and use, easily obtained raw materials, short treatment time, quick wound healing, and low treatment cost, and is particularly popular in broad rural patients.

The invention provides a non-invasive skin treatment device (100) comprising an r.f. treatment electrode (10); a return electrode (40); an r.f. generator (20) configured and arranged such that, during treatment, an r.f. treatment signal is applied between the r.f. treatment electrode (10) and the return electrode (40) for heating an inner region (15) of skin; an impedance measurement circuit (35) configured and arranged to measure, before treatment of the inner region, an initial skin impedance (Zo) between the r.f. treatment electrode (10) and the return electrode (40); and a treatment settings determiner (30) configured and arranged to determine, before treatment of the inner region (15), treatment settings associated with the r.f. treatment signal depending on the initial skin impedance (Zo) and on a dimension of the r.f. treatment electrode (10) in the contact plane, the treatment settings comprising at least one of a treatment duration (TD) associated with a desired treatment result, and an r.f. electrical parameter associated with the r.f. treatment signal. The skin treatment device (100) further comprises a controller (25) configured and arranged to consecutively activate the impedance measurement circuit (35) and the treatment settings determiner (30) before treatment of the inner region (15), configure the r.f. generator (20) to provide the r.f. treatment signal according to the treatment settings, and activate the r.f. generator (20) to apply the r.f. treatment signal to the inner region (15) for the treatment duration (TD). The invention is based on the insight obtained from multiple measurements made during the creation of microscopic thermal lesions in an inner region of skin by applying r.f. measurement and treatment signals. By analyzing the histological and heating results, a relationship was obtained between the initial impedance (Zo), the dimension of the r.f. treatment electrode (10), and the treatment settings required to obtain a particular skin treatment result. This relationship has been found to be relatively constant for different subjects, different treatment locations on the body and different skin moisture contents. The invention makes it possible to preset or predetermine, i.e. in advance, the treatment duration (TD) and / or the r.f. electrical parameters associated with the r.f. treatment signal accurately enough to avoid undesired skin damage during the treatment. The device can be simpler, as it is no longer essential to continuously monitor the impedance during treatment to determine the onset of undesired skin damage, such as ablation, which is the safety feature known from conventional devices.

The invention provides a radio-frequency electrode treatment catheter and a radio-frequency electrode treatment device. The radio-frequency electrode treatment catheter comprises a catheter and at least one group of radio-frequency electrodes, wherein one or more groups of radio-frequency electrodes are arranged on the catheter, each group of radio-frequency electrodes comprises a plurality of first radio-frequency electrode units and second radio-frequency electrode units corresponding to each other, each of the first radio-frequency electrode units and the second radio-frequency electrode units is alternately arranged on the surface of the catheter at intervals along at least one direction, and radio-frequency power supplies applied by the first radio-frequency electrode units and the second radio-frequency electrode units are opposite in polarity. The treatment catheter for treating vascular diseases is improved, the electric conduction situation between different radio-frequency electrodes is avoided, a better curative effect can be achieved in the vascular disease treatment process, the treatment duration is prolonged by virtue of ingenious interval, and then the convenience in treatment is improved.

A non-invasive apparatus for dynamic motion therapy in a weightless environment include a vibration table having a non-rigidly supported platform for generating resonant vibration and for externally transferring vibrations to the musculoskeletal system, and ankle belts or other securing means to secure a person to the vibration table. The method of providing dynamic motion therapy to a person in a weightless environment includes the steps of (a) providing a vibration table having a non-rigidly supported platform; (b) securing the person to the non-rigidly supported platform; (c) subjecting the person to resonant vibrations generated by the non-rigidly supported platform; and (d) repeating steps (b) and (c) during a predetermined treatment duration. The predetermined treatment duration is at least the duration of the weightless environment.

The invention discloses a deep carbonation method for a thick and heavy wood plate and belongs to the technical field of wood processing. The method specifically comprises steps as follows: (1) cutting of the wood plate; (2) pre-drying treatment of the wood plate; (3) deep drying treatment; (4) carbonation treatment; (5) tempering treatment. All the steps of the method are reasonably matched, the cracking resistance and the bending resistance of the wood plate can be well improved, can be 8% and 5% lower than those of a conventional wood plate respectively and are about 40% and 20% lower than those of the wood plate treated with a traditional method, the method has the remarkable improving effect, meanwhile, the whole treatment duration of the technology is shortened by 30%-40%, the efficiency is higher, and the method has the high popularization value.

The invention relates to a method for cleaning injectors of a direct-injection controlled-ignition engine, whereby, when the said engine is operating at no load, the maximum fuel pressure at the injector is calculated first of all with a view to cleaning, by executing, for at least one predetermined engine operating speed, an iterative loop during each iteration of which the value of the pressureof the injected fuel is incremented by a predetermined value and the corresponding injection time at the said incremented pressure is determined so as to select, for each operating speed, a cleaning pressure equal either to the maximum fuel pressure that corresponds to an injection time longer than the calibrated minimum injection time determined for the said operating speed, or to a ceiling maximum pressure corresponding to a determined calibrated pressure for the engine / injectors system, if this calibrated pressure is reached while the iterative loop is being executed. Next, a cleaning treatment is applied that consists in selecting an operating speed that allows the maximum cleaning pressure, and in commanding the engine to operate with this speed applied and by programming the said cleaning pressure, for a treatment duration greater than the operating time permitted during running under such operating conditions.

A method to form a titanium nitride (TiN) hard mask in the Damascene process of forming interconnects during the fabrication of a semiconductor device, while the type and magnitude of stress carried by the TiN hard mask is controlled. The TiN hard mask is formed in a multi-layered structure where each sub-layer is formed successively by repeating a cycle of processes comprising TiN and chlorine PECVD deposition, and N2 / H2 plasma gas treatment. During its formation, the stress to be carried by the TiN hard mask is controlled by controlling the number of TiN sub-layers and the plasma gas treatment duration such that the stress may counter-balance predetermined external stress anticipated on a conventionally made TiN hard mask, which causes trench sidewall distortion, trench opening shrinkage, and gap filling problem.

The invention discloses a medical fixing device for leg fracture. The medical fixing device comprises a fixing machine body, wherein a fixing treatment cavity which is through in the front-back direction is formed in the fixing machine body; a switch cavity with an upward opening is formed in the upper wall in the fixing treatment cavity in a communicating manner; a switch supporting shaft with atorsional spring inside is rotatably arranged on the right side between the front wall and the rear wall in the switch cavity; and the left side of the end surface of the outer circle of the switch supporting shaft is fixedly connected with a switch closing plate. Two sides of a leg of a patient are stably clamped in a size-adaptive manner, the effect of high treatment efficiency of the leg of thepatient is achieved, the device is fixed on the ground through a stable supporting plate, the movement vibration degree of the device is reduced to the minimum, the effect of high treatment precisionof the leg of the patient is achieved, then the surface of the leg of the patient is prepared before treatment by repeatedly spraying disinfectant, the medical efficiency is high, and the treatment time of the patient is short.

The invention discloses a method for effectively killing sub-lethal damage bacteria generated in a thermal sterilization process. The method comprises the following steps: enabling staphylococcus aureus washed with sterilized saline water to be suspended in the sterilized saline water to obtain bacterial suspension; then treating the bacterial suspension by using a thermal-ultrasonic combination sterilization method at the ultrasonic treatment frequency of 10 to 30 kHz, the treatment power of 500 to 700 w, the treatment duration of 5 to 7 min and the treatment temperature of 50 to 60 DEG C. According to the method, the possibility of restoration of the sub-lethal damage bacteria generated by thermal treatment under a proper condition is reduced, and the sterilization process is further optimized; the industrial application of the ultrasonic-thermal combination sterilization technology can be popularized favorably.

The invention discloses a human colorectal cancer cetuximab drug-resistant cell line, and belongs to the field of biomedical technology. The human colorectal cancer cetuximab drug-resistant cell linehas the advantages that a human colorectal cancer cell line NCI-H508 is treated by the cetuximab of different concentration, and the drug concentration for survival of 50% of cells is used as the initial concentration to treat the cells for a long time, until the cell NCI-H508 can normally grow under the concentration; the cell NCI-H508 is continued to treat for a long time by a gradual increasingmethod, the treatment duration is six months, and finally the human colorectal cancer cetuximab drug-resistant cell line NCI-H508 / C225 which can quickly grow under the treatment function of the cetuximab can be finally obtained; the human colorectal cancer cetuximab drug-resistant cell line can be used for analyzing the phenotypic change of morphology and biology after drug resistance of human colorectal cancer cetuximab, studying the molecule mechanism of the human colorectal cancer cetuximab drug resistance and the reversing drug resistance method, screening other anti-tumor drugs, findingthe tumor drug-resistant markers, and screening and evaluating the novel antitumor drugs and the like, and the scientific and research value and the production and application value are higher.

The invention discloses a thrombolysis device promoting absorption of medicine by using ultrasonic waves, and belongs to the technical field of medical instruments. The thrombolysis device promoting absorption of medicine by using ultrasonic waves comprises an operating handle, a medicine release catheter and an ultrasonic guide wire, wherein the operating handle is fixedly connected with the medicine release catheter through a Ruhr joint; and the operating handle consists of a casing, an ultrasonic generator, an ultrasonic transducer, a battery, an ultrasonic switch and an ultrasonic adjusting knob. The thrombolysis device promoting absorption of medicine by using ultrasonic waves performs continuous ultrasonic cavitation treatment on the thrombolysis medicine at a thrombus part, and greatly promotes penetration and dissolution of thrombus by the thrombolysis medicine; the ultrasonic guide wire is located in a medicine release catheter, and does not make contact with blood vessel walls or damage blood vessel walls and surrounding tissue. When used for clearing thrombus, the thrombolysis device promoting absorption of medicine by using ultrasonic waves has the advantages of good thrombolysis effects, short treatment time, simple operation, safety, reliability and the like.